---
figid: PMC9463785__13020_2022_663_Fig1_HTML
figtitle: Weipiling decoction alleviates N-methyl-N-nitro-N′-nitrosoguanidine-induced
  gastric precancerous lesions via NFKB signalling pathway inhibition
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9463785
filename: 13020_2022_663_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9463785/figure/Fig1/
number: F1
caption: Anti-gastric precancerous lesions (GPLs) and protein–protein interaction
  (PPI) network of potential weipiling (WPL) targets. A Venn diagram of 146 common
  targets. B The PPI network of 146 targets was constructed using the STRING database
  and Cytoscape software 3.8.0. C The top ten hub targets were selected from the PPI
  network (B)
papertitle: Weipiling decoction alleviates N-methyl-N-nitro-N′-nitrosoguanidine-induced
  gastric precancerous lesions via NF-κB signalling pathway inhibition.
reftext: Penghui Yang, et al. Chin Med. 2022;17:104.
year: '2022'
doi: 10.1186/s13020-022-00663-y
journal_title: Chinese Medicine
journal_nlm_ta: Chin Med
publisher_name: BioMed Central
keywords: Weipiling decoction | Gastric precancerous lesion | NF-κB | N-methyl-N-nitro-N-nitrosoguanidine
  | Inflammation
automl_pathway: 0.7966408
figid_alias: PMC9463785__F1
figtype: Figure
redirect_from: /figures/PMC9463785__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9463785__13020_2022_663_Fig1_HTML.html
  '@type': Dataset
  description: Anti-gastric precancerous lesions (GPLs) and protein–protein interaction
    (PPI) network of potential weipiling (WPL) targets. A Venn diagram of 146 common
    targets. B The PPI network of 146 targets was constructed using the STRING database
    and Cytoscape software 3.8.0. C The top ten hub targets were selected from the
    PPI network (B)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GAST
  - HLA-G
  - GHSR
  - GSR
  - SST
  - MTHFR
  - PLAU
  - F3
  - CCND1
  - CYP1A1
  - ABCC2
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - PCNA
  - THBS1
  - THBS2
  - THBS3
  - THBS4
  - COMP
  - DPP4
  - GSTM2
  - GNA11
  - TLR2
  - BAX
  - LIN9
  - POR
  - VDAC2
  - NFE2L2
  - CCL2
  - EGFR
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CD36
  - GRP
  - LSM4
  - LGALSL
  - UCMA
  - MYC
  - UBC
  - RPS27A
  - JUN
  - JUNB
  - JUND
  - RELA
  - CREBBP
  - MPO
  - TYMS
  - TOP1
  - RB1
  - RBM45
  - CALM1
  - INS
  - AR
  - CAT
  - CRAT
  - GLYAT
  - VEGFA
  - LEP
  - HLA-A
  - EP300
  - HSP90AA1
  - SLC2A1
  - SLC2A2
  - SLC2A3
  - SLC2A4
  - SLC2A5
  - SLC2A6
  - SLC2A7
  - SLC2A8
  - SLC2A9
  - SLC2A10
  - SLC2A11
  - SLC2A12
  - SLC2A14
  - OPRM1
  - BDNF
  - BDNF-AS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GSTP1
  - INSR
  - IGF1R
  - INSRR
  - CFTR
  - ELANE
  - ABCB1
  - BCL2
  - CYCS
  - IGF1
  - CDK1
  - NTS
  - GPC3
  - B2M
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - ALDH2
  - FASN
  - CTSB
  - CCKBR
  - CYP3A4
  - ADAM17
  - PTGS2
  - TNF
  - CASP3
  - AKT1
  - IL6
  - TP53
  - HIF1A
  - STAT3
---
